Faron Pharmaceuticals (UK) Buy Hold or Sell Recommendation
| FARN Stock | 170.00 2.50 1.49% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Faron Pharmaceuticals Oy is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Faron Pharmaceuticals Oy given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Faron Pharmaceuticals Oy, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Faron Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Faron and provide practical buy, sell, or hold advice based on investors' constraints. Faron Pharmaceuticals Oy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Faron |
Execute Faron Pharmaceuticals Buy or Sell Advice
The Faron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Faron Pharmaceuticals Oy. Macroaxis does not own or have any residual interests in Faron Pharmaceuticals Oy or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Faron Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Faron Pharmaceuticals Trading Alerts and Improvement Suggestions
| Faron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Faron Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (30.94 M) with profit before overhead, payroll, taxes, and interest of 803 K. | |
| Faron Pharmaceuticals generates negative cash flow from operations | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Halyk Bank receives investment-grade rating from SP By Investing.com - Investing.com |
Faron Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Faron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Faron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Faron Pharmaceuticals Returns Distribution Density
The distribution of Faron Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Faron Pharmaceuticals' future price movements. The chart of the probability distribution of Faron Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Faron Pharmaceuticals Oy price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Faron Pharmaceuticals returns is essential to provide solid investment advice for Faron Pharmaceuticals.
| Mean Return | -0.33 | Value At Risk | -5.26 | Potential Upside | 6.94 | Standard Deviation | 3.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Faron Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Faron Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 3.0M | (3.0M) | 2.7M | 137K | (114K) | (108.3K) | |
| Free Cash Flow | (11.6M) | (17.6M) | (22.7M) | (23.4M) | (23.9M) | (22.7M) | |
| Depreciation | 238K | 283K | 307K | 300K | 346K | 198.9K | |
| Other Non Cash Items | 158K | (438K) | (1.2M) | (626K) | 1.1M | 1.2M | |
| Capital Expenditures | 100K | 142K | 474K | 385K | 123K | 243.7K | |
| Net Income | (13.3M) | (16.9M) | (21.2M) | (28.7M) | (30.9M) | (29.4M) | |
| Net Borrowings | 156K | 313K | 349K | 10.2M | 11.7M | 12.3M | |
| Change To Netincome | 164K | 56K | 430K | 671K | 771.7K | 399.3K | |
| End Period Cash Flow | 7.1M | 4.1M | 6.9M | 7.0M | 6.9M | 5.4M | |
| Investments | (100K) | (142K) | (473K) | (385K) | (123K) | (129.2K) |
Faron Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Faron Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Faron Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Faron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.41 | |
β | Beta against Dow Jones | 0.81 | |
σ | Overall volatility | 3.70 | |
Ir | Information ratio | -0.12 |
Faron Pharmaceuticals Volatility Alert
Faron Pharmaceuticals Oy exhibits very low volatility with skewness of -0.06 and kurtosis of 1.64. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Faron Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Faron Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Faron Pharmaceuticals Fundamentals Vs Peers
Comparing Faron Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Faron Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Faron Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Faron Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Faron Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Faron Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Faron Pharmaceuticals to competition |
| Fundamentals | Faron Pharmaceuticals | Peer Average |
| Return On Equity | -39.61 | -0.31 |
| Return On Asset | -0.7 | -0.14 |
| Current Valuation | 163.6 M | 16.62 B |
| Shares Outstanding | 104.62 M | 571.82 M |
| Shares Owned By Insiders | 31.81 % | 10.09 % |
| Shares Owned By Institutions | 10.35 % | 39.21 % |
| Price To Book | 156.09 X | 9.51 X |
| Price To Sales | 16.21 X | 11.42 X |
| Gross Profit | 803 K | 27.38 B |
| EBITDA | (28.37 M) | 3.9 B |
| Net Income | (30.94 M) | 570.98 M |
| Total Debt | 13.11 M | 5.32 B |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (23.81 M) | 971.22 M |
| Earnings Per Share | (0.31) X | 3.12 X |
| Target Price | 1009.02 | |
| Number Of Employees | 34 | 18.84 K |
| Beta | 0.33 | -0.15 |
| Market Capitalization | 177.86 M | 19.03 B |
| Total Asset | 10.22 M | 29.47 B |
| Retained Earnings | (172.21 M) | 9.33 B |
| Working Capital | (6.14 M) | 1.48 B |
| Net Asset | 10.22 M |
Faron Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Faron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Faron Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Faron Pharmaceuticals Oy? Buying financial instruments such as Faron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Faron Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaurants Thematic Idea Now
Restaurants
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaurants Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.